François-Xavier Lamy

François-Xavier Lamy currently serves as an Expert in the safety of substances of human origin at the European Centre for Disease Prevention and Control (ECDC) since April 2022. Previously, François-Xavier held the position of Real World Evidence Excellence Lead at UCB, overseeing protocol reviews for scientific standards in real-world evidence studies from April 2021 to March 2022. François-Xavier's experience includes serving as Associate Director of Global Epidemiology at Merck KGaA, where responsibilities included designing real-world data studies in oncology, and as Head of Epidemiological Development at ICTA, providing medical and scientific counsel. Additional roles include Epidemiologist Research Manager at Lundbeck, project management in epidemiological studies at Agence de la biomédecine, and project officer for a European organ donation initiative. François-Xavier's academic credentials feature multiple degrees in public health, epidemiology, and cellular biology from Université de Bordeaux and Université de Rennes I.